13 of 68 industrial liquidation sales this fall are biotech or pharma equipment.
One of the auctions is called "Pfizer #162". The auction house labels it Sale #162. It covers bioreactors, chromatography systems and centrifuges at five locations, from Mansfield, Massachusetts to Bothell, Washington, and bidding ends on December 16. It is one of 76 listings I pulled on November 12 from six US liquidation houses. These are the firms a company calls when a plant shuts, a lender…
Thirteen out of the 68 industrial equipment liquidation sales happening this fall are related to biotech or pharmaceutical companies. One of the auctions is known as Pfizer #162, which covers bioreactors, chromatography systems, and centrifuges across multiple locations. The auction closes on December 16 and is one of 76 listings gathered from six US liquidation firms.
Of these 76 listings, 13 are biotech or pharmaceutical equipment sales. The information was collected using a program called Industry Auction Signals, which pulled all available data from the six houses within the previous 60 days. The sales typically occur after a plant closure, lender foreclosure, or when a lab has excess equipment.
The data, which does not include cancelled sales or individual estates, is presented in a clear and concise manner, showing the location, end date, and types of equipment involved in each sale.
Written by urgent.news from Dev.to's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
